Status:
COMPLETED
Kinesiophobia in Postmenopausal Osteoporosis
Lead Sponsor:
Beylikduzu State Hospital
Conditions:
Osteoporosis
Eligibility:
FEMALE
50+ years
Brief Summary
This study aims to evaluate kinesiophobia levels in postmenopausal women with osteoporosis compared to a healthy control group and to explore the relationships between kinesiophobia and various psycho...
Detailed Description
This cross-sectional, controlled study aims to explore kinesiophobia levels in postmenopausal women with osteoporosis compared to healthy age-matched controls. Postmenopausal osteoporosis is a systemi...
Eligibility Criteria
Inclusion
- Diagnosis: Participants must be diagnosed with postmenopausal osteoporosis and have been under follow-up for at least six months.
- Age: Individuals must be 50 years or older.
- Health Status: Participants must have excluded secondary causes of osteoporosis.
Exclusion
- Comorbid Conditions: Presence of other musculoskeletal, neurological, or psychiatric diseases that could influence kinesiophobia or pain.
- Cognitive or Communication Difficulties: Any cognitive dysfunction or communication issues that might impair the participant's ability to engage with the study.
- Acute Conditions: Presence of acute painful conditions that might affect the results.
- Medications: Use of medications or presence of diseases that could cause balance or functional disorders.
Key Trial Info
Start Date :
January 21 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 21 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06520709
Start Date
January 21 2024
End Date
February 21 2024
Last Update
July 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beylikdüzü State Hospital
Istanbul, Turkey (Türkiye), 34147